Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00328341 · ClinicalTrials.gov registry record

The Use of Tissue Oxygen Monitoring in Critically Injured Patients

A clinical trial, sponsored by University of California, San Francisco.

Terminated
Registry status
67
Enrollment target

NCT00328341 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 67 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00328341 was terminated before completion, sponsored by University of California, San Francisco.

TERMINATED
Registry status
67 participants
Enrollment target

Study Summary

It is anticipated that the use of tissue oxygen monitoring to measure brain tissue oxygen and deltoid muscle oxygen will provide more precise information about focal brain ischemia and systemic hypoperfusion than current techniques and measures such as blood pressure, heart rate and intracranial pressure. Understanding the relationship between tissue oxygen tension collected from the brain and deltoid muscle in critically injured patients could lead to a broader understanding of the important metabolic and cellular events that occur following severe injury and the changes induced by therapeutic interventions. Furthermore, the use of interventions designed to improve tissue hypoxia, as measured by low brain or muscle tissue oxygen, may improve mortality or neurological recovery after systemic trauma or head trauma compared to current approaches that do not involve tissue metabolic monitoring.

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2006-04
Est. Completion 2011-12

What the Registry Record Tells You About NCT00328341

The ClinicalTrials.gov registry entry for NCT00328341 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00328341 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00328341 about?

NCT00328341 is a clinical study titled "The Use of Tissue Oxygen Monitoring in Critically Injured Patients". It is anticipated that the use of tissue oxygen monitoring to measure brain tissue oxygen and deltoid muscle oxygen will provide more precise information about focal brain ischemia and systemic hypoperfusion than current techniques and measures such as blood pressure, heart rate and intracranial pre...

What is the current status of trial NCT00328341?

This trial is currently terminated. The enrollment target is 67 participants. The study started on 2006-04. Estimated completion is 2011-12.

Who is sponsoring clinical trial NCT00328341?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.